Jarrett Jennifer

Jarrett Jennifer is listed in filings as Director at Syndax Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Apr 1, 2026, including sale activity. Recent filings connect the profile to Syndax Pharmaceuticals, Inc. (SNDX), Sagimet Biosciences Inc. (SGMT), Arcus Biosciences, Inc. (RCUS), and Damora Therapeutics, Inc. (DMRA). The current snapshot covers public activity from Jun 18, 2024 to Apr 1, 2026. Reported amounts are shown as $396.4K to $215.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.